| Arpita Singh Sukhi, | |
|
5059 Business Center Dr, Fairfield, CA 94534-1631 | |
| (707) 863-0727 | |
| Not Available |
| Full Name | Arpita Singh Sukhi |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 5059 Business Center Dr, Fairfield, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144969189 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | RPH80243 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Arpita Singh Sukhi, 5059 Business Center Dr, Fairfield, CA 94534-1631 Ph: () - | Arpita Singh Sukhi, 5059 Business Center Dr, Fairfield, CA 94534-1631 Ph: (707) 863-0727 |
News Archive
"Treating tuberculosis (TB) and HIV infections at the same time can be a challenge for patients and their doctors, but attacking both diseases early and aggressively isn't harmful and could save the lives of those who are sickest," according to a global study led by researchers from the University of California, San Francisco (UCSF) and published Wednesday in the New England Journal of Medicine (NEJM), the San Francisco Chronicle reports.
To investigate factors that can jeopardize pregnancy success in cattle, researchers at the University of São Paulo (USP) in Brazil used a kind of chip to mimic the environment of the endometrium, the tissue that lines the inside of the uterus.
Cell Therapeutics, Inc., a company focused on translating science into novel cancer therapies, today announced the initiation of the commercial launch of Pixuvri in the European Union with entry into Sweden, Denmark and Finland in September, to be followed by Austria and Norway in early October 2012 and Germany, United Kingdom and the Netherlands in November 2012.
People who experience brief periods of blocked blood flow may be better conditioned to survive a full-blown heart attack later, according to new research from the University of Cincinnati (UC).
Cell Therapeutics, Inc. announced that it has received a letter from The NASDAQ Stock Market LLC, indicating that CTI has regained compliance with the minimum bid price rule (i.e., NASDAQ Listing Rule 5550(a)(2)) for continued listing on The NASDAQ Capital Market and that CTI is in compliance with all applicable listing standards.
› Verified 7 days ago
Iman Musallam, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1550 Gateway Blvd, Fairfield, CA 94533 Phone: 707-427-4208 | |
Ms. Diane Hao Tonnu, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 101 Bodin Circle, Fairfield, CA 94533 Phone: 707-423-7657 | |
Heather Martin, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1550 Gateway Blvd, Fairfield, CA 94533 Phone: 707-427-4302 Fax: 707-427-4380 | |
Ms. Yingfeng Qiao, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2117 Beaujolais Ct, Fairfield, CA 94533 Phone: 415-305-4759 | |
Dr. Deborah Beauchamp, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3330 N Texas St, Fairfield, CA 94533 Phone: 707-421-9010 Fax: 707-421-9484 | |
Neil H Sandow, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1330 Gateway Blvd, Fairfield, CA 94533 Phone: 707-422-0500 Fax: 707-422-0555 | |
Carol Ritzinger, PHARMACYD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1200 B Gale Wilson Blvd, Fairfield, CA 94533 Phone: 707-646-5000 |